-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, T4bXfB3jOpFCbsxc1SVqpRHe4y71SKR5IpxUQLMz68vT8Etbn4Ful8R6Ocfru+1F vXLgIeR/GGbpUsU6aRphbA== 0001181431-07-039038.txt : 20070608 0001181431-07-039038.hdr.sgml : 20070608 20070608184145 ACCESSION NUMBER: 0001181431-07-039038 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070607 FILED AS OF DATE: 20070608 DATE AS OF CHANGE: 20070608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSCIENT PHARMACEUTICALS CORP CENTRAL INDEX KEY: 0000356830 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042297484 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 WINTER STREET STREET 2: SUITE 2200 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 7813982300 MAIL ADDRESS: STREET 1: 1000 WINTER STREET STREET 2: SUITE 2200 CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: GENOME THERAPEUTICS CORP DATE OF NAME CHANGE: 19941215 FORMER COMPANY: FORMER CONFORMED NAME: COLLABORATIVE RESEARCH INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RIEDEL NORBERT G CENTRAL INDEX KEY: 0001161662 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-10824 FILM NUMBER: 07910935 BUSINESS ADDRESS: BUSINESS PHONE: 8479483980 MAIL ADDRESS: STREET 1: BAXTER INTERNATIONAL INC STREET 2: ONE BAXTER PKWY DF2-2W CITY: DEERFIELD STATE: IL ZIP: 60015 4 1 rrd162106.xml FORM 4 X0202 4 2007-06-07 0 0000356830 OSCIENT PHARMACEUTICALS CORP OSCI 0001161662 RIEDEL NORBERT G 1000 WINTER ST. SUITE 2200 WALTHAM MA 02451 1 0 0 0 Common Stock 2007-06-07 4 A 0 300 0 A 1040 D Stock Options (right to buy) 4.91 2007-06-07 4 A 0 750 0 A 2017-06-06 Common Stock 750 750 D Restricted Shares issued under the Company's 2001 Incentive Plan and will vest in equal annual installments over two years. Stock Options issued under the Company's 2001 Incentive Plan and will vest in equal annual installments over two years. Jospeh D. Vittiglio, Esq., Director of Corporate Legal Affairs - Power of Attorney 2007-06-08 -----END PRIVACY-ENHANCED MESSAGE-----